3D Cell Culture Market Is Expected To Boom Worldwide By 2027

1. MarketsandMarkets Presents 3D Cell Culture Market worth $2.6 billion by 2027 https://www.marketsandmarkets.com/Market-Reports/3d-cell-culture-market-191072847.html

2. The report "3D Cell Culture Market by Type (Hydrogel, ECM, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharma, Biotech, Research, Cosmetics), Region - Global Forecast to 2027", is valued at an estimated USD 1.3 billion in 2022 and is projected to reach USD 2.6 billion by 2027, at a CAGR of 15.6% during the forecast period. The growth of this market is mainly driven by factors such as the increasing focus on developing alternative methods to animal testing, growing focus on personalized medicine, increasing incidence of chronic diseases, and the availability of funding for research. On the other hand, a lack of infrastructure for 3D cell-based research and the high cost of cell biology research are expected to restrain the growth of this market during the forecast period. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownload

3. Objectives of the Study: • To define, describe, and forecast the 3D cell culture market based on product, application, end user, and region • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges) • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall 3D cell culture market • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), and the Middle East & Africa (MEA) • To profile the key players and analyze their market shares and core competencies • To track and analyze competitive developments, such as product launches, funding and grants, partnerships, agreements, collaborations, expansions, strategic alliances, and acquisitions in the 3D cell culture market • To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy • Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalyst

4. This report categorizes the 3D Cell Culture market into the following segments and subsegments: • 3D Cell Culture Market, by Type • Scaffold-based 3D Cell Cultures • Scaffold-free 3D Cell Cultures • Microfluidics-based 3D Cell Cultures • Magnetic & Bioprinted 3D Cell Cultures • 3D Cell Culture Market, by Application • Cancer & Stem Cell Research • Drug Discovery & Toxicology Testing • Tissue Engineering & Regenerative Medicine • 3D Cell Culture Market, by End user • Pharmaceutical & Biotechnology Companies • Research Institutes • Cosmetics Industry • Other End Users

5. Key players in the 3D Cell Culture market include Thermo Fisher Scientific (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza Group AG (Switzerland), Avantor Inc. (US), Tecan Trading AG (Switzerland), REPROCELL Inc. (Japan), 3D Biotek LLC. (US), Emulate Inc. (US), CN Bio Innovations (UK), Synthecon Incorporated (US), and InSphero AG (Switzerland) and Among others

6. Company Insights Thermo Fisher Scientific (US) offers 3D cell culture products through its Biosciences segment. Thermo Fisher has a wide customer base, including pharmaceutical and biotechnology companies, hospitals and clinical laboratories, universities, research institutions, government agencies, and environmental and process control industries. The company has a strong geographic footprint and operates in more than 150 countries across North America, Europe, Latin America, and Asia. From 2019 to 2021, Thermo Fisher Scientific has engaged in strategic developments such as product launches, acquisitions, and geographic expansion. Thermo Fisher Scientific is expected to witness significant growth in the global 3D cell culture market with its strong product portfolio, continuous research and development activities, and broad geographic reach. Merck KGaA (Germany) provides 3D cell culture products through its Research Solutions and Process Solutions business units. The company has focused on strategies such as collaborations to strengthen its position in this market. For instance, in May 2021, Merck collaborated with TU Darmstadt and Tufts University on Bioreactor designs to enable cultured meat production. The company also expanded its geographic presence by establishing the Merck Biotech Development Center in Switzerland. It invests substantially in R&D to provide innovative products. In 2021, the company invested USD 2.85 billion in R&D compared to USD 2.61 billion in 2020. With its strong R&D capabilities and product portfolio, the company is expected to maintain its leading position in the market.

7. Contact Us Contact:Mr. Aashish MehraMarketsandMarkets™ INC. 630 Dundee Road, Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 sales@marketsandmarkets.com Press release: https://www.marketsandmarkets.com/PressReleases/3d-cell-culture.asp Research insights: https://www.marketsandmarkets.com/ResearchInsight/3d-cell-culture-market.asp

8. About MarketsandMarkets MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.